Home > Insider Trading > Filing (0001209191-11-044215)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
786947	Acura Pharmaceuticals Inc	ACUR	Pharmaceutical Preparations (2834)	110853640

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1107934	F James Emigh	C/O Acura Pharmacuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067	Vp Marketing & Administration	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-08-12	100	$2.56	166,325	No	4	P	Direct
Common Stock	Acquisiton	2011-08-12	986	$2.58	167,311	No	4	P	Direct
Common Stock	Acquisiton	2011-08-12	300	$2.59	167,611	No	4	P	Direct
Common Stock	Acquisiton	2011-08-12	2,200	$2.60	169,811	No	4	P	Direct
Common Stock	Acquisiton	2011-08-12	300	$2.61	170,111	No	4	P	Direct
Common Stock	Acquisiton	2011-08-12	400	$2.62	170,511	No	4	P	Direct
Common Stock	Acquisiton	2011-08-12	714	$2.64	171,225	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Holdings include 116,625 Restricted Stock Units. Absent a change of control, shares of common stock will be distributed under the Restricted Stock Units (after payment of $.01 par value per share) in three equal installments on January 1st of each of 2012, 2013 and 2014. If a change of control occurs, one share of common stock will be distributed for each outstanding Restricted Stock Unit (after payment of $0.01 per share par value) at or about the time of the change of control.